NeuroMetrix jumps on FDA application for fibromyalgia device

NeuroMetrix

07/10/2021 11:38

** Medical device maker's  NURO.O  shares jump 15.9% to
$9.99, set for their best day since Sept. 21
    ** NURO announces submission of a regulatory request for
approval to market its wearable nerve-stimulation device Quell
as a prescription treatment for fibromyalgia in adults
 urn:newsml:reuters.com:*:nGNXptdhm
    ** Fibromyalgia is a common chronic pain disorder,
accompanied by fatigue, sleep, memory and mood disturbances
    ** Up to Wednesday's close, stock had gained 172.8% this
year

 (Reporting by Bansari Mayur Kamdar)
 ((BansariMayur.Kamdar@thomsonreuters.com;))